Company Filing History:
1 out of 14 
1 out of 30 
Years Active: 2021
Title: Frank Bruchertseifer: Innovator in Cancer Treatment
Introduction
Frank Bruchertseifer is a notable inventor based in Stutensee, Germany. He has made significant contributions to the field of cancer treatment, particularly in the area of PSMA expressing cancers. His innovative approach has the potential to improve the lives of many patients suffering from this condition.
Latest Patents
Frank Bruchertseifer holds a patent for a method of treating PSMA expressing cancers. The invention involves administering an effective amount of one or more Ac-225-radiopharmaceuticals to patients in need. The effective dosage ranges from 25 kBq to 400 kBq per kilogram of body weight or as a unitary dosage of 3 MBq to 30 MBq.
Career Highlights
Throughout his career, Frank has worked with esteemed organizations such as the European Atomic Energy Community (Euratom), represented by the European Commission, and the University of Heidelberg. His work in these institutions has allowed him to advance his research and contribute to the scientific community.
Collaborations
Frank has collaborated with notable colleagues, including Alfred Morgenstern and Christos Apostolidis. These partnerships have enriched his research and fostered innovation in cancer treatment methodologies.
Conclusion
Frank Bruchertseifer is a pioneering inventor whose work in treating PSMA expressing cancers showcases his dedication to improving patient outcomes. His innovative methods and collaborations highlight the importance of research in the fight against cancer.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.